Abstract
The majority of hyperphenylalaninemias (HPAs) result from mutations at the gene for phenylalanine hydroxylase (PAH). The broad phenotypic variability of these conditions, ranging from phenylketonuria (PKU) to mild benign HPA, is underlain by a wide spectrum of mutations giving rise to various genotypic combinations. Mutant PAH alleles, labeled by specific polymorphic haplotypes and mutations, are becoming useful markers in human population genetics. We report here a mutant PAH allele found in Jews from Morocco and Tunisia, marked by haplotype 4 and a missense mutation, TCASer→CCApro, at codon 349 in exon 10 of the gene. In vitro expression of the mutation showed normal levels of mRNA with virtually no enzymatic activity or protein immunoreactivity, pointing to a highly unstable protein. A homozygote for this mutation showed the most severe (“classical”) type of PKU, while compound heterozygotes showed two other types of HPA — “atypical” PKU and “high benign” HPA — illustrating the interplay between different mutations that gives rise to various HPAs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Avigad S, Cohen BE, Bauer S, Schwartz G, Frydman M, Woo SLC, Niny Y, Shiloh Y (1990) A single origin of phenylketonuria in Yemenite Jews. Nature 344:168–170
Avigad S, Kleiman S, Weinstein M, Cohen BE, Schwartz G, Woo SLC, Shiloh Y (1991) Compound heterozygosity in non-PKU hyperphenylalaninemia: the contribution of mutations for classical PKU. Am J Hum Genet 49:393–399
Berthelon M, Caillaud C, Rey F, Labrune P, Melle D, Feingold J, Frezal J, Briard M-L, Farriaux J-P, Guibaud P, Journel H, Maurin N, Le Marrec B, Nivelon J-L, Plauchu H, Saudubray J-M, Tron P, Rey J, Munnich A, Lyonnet S (1991) Spectrum of phenylketonuria mutations in Western Europe and North Africa, and their relation to polymorphic DNA haplotypes at the phenylalanine hydroxylase locus. Hum Genet 86:355–358
Blascovics ME, Schaeffler GE, Hacks S (1974) Phenylalaninemia: differential diagnosis. Arch Dis Child 49:835–843
Chu G, Hayakawa H, Berg P (1987) Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res 15:1311–1326
Cohen BE, Szeinberg A, Levine T, Peled I, Pollack S, Crispin M, Normand M (1978) Phenylketonuria in Israel. Monogr Hum Genet 9:95–101
Eisensmith RC, Woo SLC (1991) Phenylketonuria and the phenylalanine hydroxylase gene. Mol Biol Med 8:3–18
Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13
Forrest SM, Dahl HH, Howells DW, Dianzani I, Cotton RGH (1991) Mutation detection in phenylketonuria by using chemical cleavage of mismatch: importance of using probes from both normal and patient samples. Am J Hum Genet 49:175–183
Guthrie R, Susi A (1963) A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32:338–343
Guttler F, Lou H (1990) Phenylketonuria and hyperphenylalaninemia. In: Fernandes J, Saudubray JM, Tada K (eds) Inborn metabolic diseases — diagnosis and treatment. Springer, Berlin Heidelberg New York, pp 161–174
Konecki DS, Lichter-Konecki U (1991) The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations. Hum Genet 87:377–388
Kwok SCM, Ledley FD, DiLella AG, Robson KJH, Woo SLC (1985) Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Bio-chemistry 24:556–561
Ledley FD, Grenett HE, DiLella AG, Kwok SCM, Woo SLC (1985) Gene transfer and expression of human phenylalanine hydroxylase. Science 228:77–79
Ledley FD, Grenett HE, Woo SLC (1987) Biochemical characterization of recombinant human phenylalanine hydroxylase produced in Escherichia coli. J Biol Chem 262:2228–2233
Leeming RJ, Barford PA, Blair JA, Smith I (1984) Blood spots on Guthrie cards can be used for inherited tetrahydrobiopterin deficiency screening in hyperphenylalaninemic infants. Arch Dis Child 59:58–61
Lidsky AS, Ledley FD, DiLella AG, Kwok SCM, Daiger SP, Robson KJH, Woo SLC (1985) Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet 37:619–634
Niederwieser A, Curtis H-C, Wang M, Leopold D (1982) Atypical phenylketonuria with defective biopterin metabolism. Eur J Pediatr 138:111–112
Nielsen DA, Chou J, MacKrell AJ, Casadaban MJ, Steiner DF (1983) Expression of a preproinsulin-β-galactosidase gene fusion in mammalian cells. Proc Natl Acad Sci USA 80:5198–5202
Okano Y, Eisensmith RC, Guttler F, Lichter-Konecki U, Konecki DS, Trefz FK, Dasovich M, Wang T, Henriksen K, Lou H, Woo SLC (1991a) Molecular basis of phenotypic heterogeneity in PKU. New Engl J Med 324:1232–1238
Okano Y, Eisensmith RC, Dasovich M, Wang T, Guttler F, Woo SLC (1991b) A prevalent missense mutation in Northern Europe associated with hyperphenylalaninemia. Eur J Pediatr 150:347–352
Robson KJH, Chandra T, MacGillivary RJA, Woo SLC (1982) Polysome immunoprecipitation of phenylalanine hydroxylase mRNA from rt liver and cloning of its cDNA. Proc Natl Acad Sci USA 79:4701–4705
Sakai K, Kanda N, Shiloh Y, Donlon T, Shipley J, Dryja T, Latt S (1985) Molecular and cytological analysis of DNA amplification in retinoblastoma. Cancer Genet Cytogenet 17:95–112
Sambrook EF, Fritsch Y, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Scriver CR, Kaufman S, Woo SLC (1988) Mendelian hyperphenylalaninemia. Annu Rev Genet 22:301–321
Scriver CR, Kaufman S, Woo SLC (1989) The hyperphenyl-alaninemias. In: Scriver CR, Beadet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 495–546
Shiloh Y, Avigad S, Kleiman S, Weinstein M, Schwartz G, Woo SLC, Cohen BE (1991) Molecular analysis of hyperphenylalaninemia in Israel: a study of Jewish genetic diversity. In: Bonne-Tamir, Adam A (eds) Genetic diversity among jews: diseases and markers at the DNA level. Oxford University Press, England, pp 237–247
Wang T, Okano Y, Eisensmith RC, Fekete G, Schuler D, Berenscsi G, Nasz I, Woo SLC (1990) Molecular genetics of PKU in Eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somatic Cell Mol Genet 16:85–90
Wong PWK, OwFlynn ME, Inouye T (1964) Micromethods for measuring phenylalanine and tyrosine in serum. Clin Chem 10:1098–1104
Woo SLC (189a) Molecular basis and population genetics of phenylketonuria. Biochemistry 28:1–7
Woo SLC (1989b) Collation of RFLP haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet 43:781–783
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinstein, M., Eisensmith, R.C., Abadie, V. et al. A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in North African Jews with phenylketonuria. Hum Genet 90, 645–649 (1993). https://doi.org/10.1007/BF00202483
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00202483